atai Life Sciences (ATAI) Tops Q3 EPS by 2c

atai Life Sciences (NASDAQ: ATAI) reported Q3 EPS of ($0.22), $0.02 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $24M .

For earnings history and earnings-related data on atai Life Sciences (ATAI) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Nike names former Pfizer CFO David Denton as new finance chief